XML 51 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Cash position - Narrative (Details)
€ in Thousands, $ in Millions
6 Months Ended
Jun. 30, 2020
EUR (€)
tranche
Jun. 30, 2019
EUR (€)
Jun. 30, 2020
USD ($)
Jun. 30, 2020
EUR (€)
Dec. 31, 2019
USD ($)
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
EUR (€)
Cash and cash equivalents              
Current financial investments and cash and cash equivalents   € 1,147,923   € 5,566,496   € 5,780,800  
Increase/decrease (-) in current financial instruments and cash and cash equivalents € (214,300) (142,900)          
Cash reported, operating activities (209,829) (141,740)          
Operational cash burn (230,486) (152,545)          
Proceeds from issuance of shares net of issuance cost 23,300            
Proceeds from capital and share premium increases from exercise of subscription rights 23,268 7,805          
(Fair) value of current financial investments and unrealized positive exchange rate differences (7,100)            
Term deposits       1,169,245   953,677  
Cash and cash equivalents   € 1,147,923   2,384,220   € 1,861,616 € 1,290,796
Cash invested in highly liquid money market funds       1,439,600      
Foreign exchange gain in case of a 10% change in the EUR/U.S. dollar exchange rate € 130,400            
Research and development incentive receivables       116,600      
Treasury bills (included in current financial investments)       € 1,742,600      
U.S. Dollars              
Cash and cash equivalents              
Current financial investments and cash and cash equivalents | $     $ 1,459.8   $ 1,507.4    
Minimum              
Cash and cash equivalents              
Maturity period 3 months            
France              
Cash and cash equivalents              
Number of tranches in which R&D tax credit receivable will be paid | tranche 4